Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Nature Communications|March 11, 2015
Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemiaMaike Buchner, Eugene Park, Huimin Geng, et al.International Journal of Pharmaceutics|March 8, 2022
Utilizing in vitro drug release assays to predict in vivo drug retention in micellesAida Varela-Moreira, Heleen van Leur, Danielle Krijgsman, et al.British Journal of Haematology|August 27, 2010
The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodiesMaike Buchner, Philipp Brantner, Natalie Stickel, et al.Cancer Research|June 25, 2009
Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemiaMaike Buchner, Simon Fuchs, Gabriele Prinz, et al.Nature|August 14, 2012
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signallingMarcus Dühren-von Minden, Rudolf Übelhart, Dunja Schneider, et al.Plos One|December 31, 2016
Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic LeukemiaMarco Benkisser-Petersen, Maike Buchner, Arlette Dörffel, et al.Nature Communications|June 11, 2021
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemiaVeronika Ecker, Martina Stumpf, Lisa Brandmeier, et al.Blood Advances|January 11, 2023
Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccinationHye Kyung Lee, Manuela A Hoechstetter, Maike Buchner, et al.Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccinationHye Kyung Lee, Manuela A Hoechstetter, Maike Buchner, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2011
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient miceIngo Hilgendorf, Sara Eisele, Imke Remer, et al.Pageof 3